Vanguard Group’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,179,600
| Closed | -$711K | – | 4569 |
|
|
2023
Q2 | $711K | Hold |
2,179,600
| – | – | ﹤0.01% | 4010 |
|
|
2023
Q1 | $937K | Hold |
2,179,600
| – | – | ﹤0.01% | 3943 |
|
|
2022
Q4 | $1.16M | Buy |
2,179,600
+1,010
| +0% | +$535 | ﹤0.01% | 3858 |
|
|
2022
Q3 | $1.6M | Buy |
2,178,590
+232,000
| +12% | +$170K | ﹤0.01% | 3846 |
|
|
2022
Q2 | $2.22M | Hold |
1,946,590
| – | – | ﹤0.01% | 3762 |
|
|
2022
Q1 | $3.99M | Buy |
1,946,590
+123,731
| +7% | +$254K | ﹤0.01% | 3635 |
|
|
2021
Q4 | $5.25M | Sell |
1,822,859
-34,391
| -2% | -$99K | ﹤0.01% | 3580 |
|
|
2021
Q3 | $7.88M | Sell |
1,857,250
-18,621
| -1% | -$79K | ﹤0.01% | 3382 |
|
|
2021
Q2 | $9.92M | Buy |
1,875,871
+773,343
| +70% | +$4.09M | ﹤0.01% | 3203 |
|
|
2021
Q1 | $5.13M | Buy |
1,102,528
+67,126
| +6% | +$312K | ﹤0.01% | 3515 |
|
|
2020
Q4 | $3.42M | Buy |
1,035,402
+118,833
| +13% | +$392K | ﹤0.01% | 3505 |
|
|
2020
Q3 | $3.03M | Sell |
916,569
-27,555
| -3% | -$91.2K | ﹤0.01% | 3362 |
|
|
2020
Q2 | $3.18M | Sell |
944,124
-665,093
| -41% | -$2.24M | ﹤0.01% | 3286 |
|
|
2020
Q1 | $6.16M | Sell |
1,609,217
-64,745
| -4% | -$248K | ﹤0.01% | 2860 |
|
|
2019
Q4 | $10.1M | Buy |
1,673,962
+266,603
| +19% | +$1.61M | ﹤0.01% | 2853 |
|
|
2019
Q3 | $10.6M | Buy |
1,407,359
+174,903
| +14% | +$1.32M | ﹤0.01% | 2781 |
|
|
2019
Q2 | $16.7M | Buy |
1,232,456
+691,342
| +128% | +$9.37M | ﹤0.01% | 2601 |
|
|
2019
Q1 | $2.93M | Buy |
541,114
+274,497
| +103% | +$1.49M | ﹤0.01% | 3339 |
|
|
2018
Q4 | $792K | Sell |
266,617
-384,783
| -59% | -$1.14M | ﹤0.01% | 3632 |
|
|
2018
Q3 | $5.32M | Buy |
651,400
+125,327
| +24% | +$1.02M | ﹤0.01% | 3213 |
|
|
2018
Q2 | $5.12M | Sell |
526,073
-46,621
| -8% | -$454K | ﹤0.01% | 3209 |
|
|
2018
Q1 | $4.98M | Sell |
572,694
-26,457
| -4% | -$230K | ﹤0.01% | 3155 |
|
|
2017
Q4 | $7.5M | Buy |
599,151
+102,346
| +21% | +$1.28M | ﹤0.01% | 2965 |
|
|
2017
Q3 | $4.15M | Buy |
496,805
+18,042
| +4% | +$151K | ﹤0.01% | 3184 |
|
|
2017
Q2 | $8.13M | Buy |
478,763
+52,952
| +12% | +$899K | ﹤0.01% | 2870 |
|
|
2017
Q1 | $8.56M | Buy |
425,811
+149,094
| +54% | +$3M | ﹤0.01% | 2826 |
|
|
2016
Q4 | $4.31M | Buy |
276,717
+58,924
| +27% | +$919K | ﹤0.01% | 3118 |
|
|
2016
Q3 | $2.84M | Buy |
217,793
+13,578
| +7% | +$177K | ﹤0.01% | 3257 |
|
|
2016
Q2 | $1.4M | Sell |
204,215
-1,896
| -0.9% | -$13K | ﹤0.01% | 3504 |
|
|
2016
Q1 | $1.95M | Buy |
206,111
+137,590
| +201% | +$1.3M | ﹤0.01% | 3394 |
|
|
2015
Q4 | $690K | Buy |
68,521
+34,873
| +104% | +$351K | ﹤0.01% | 3737 |
|
|
2015
Q3 | $481K | Buy |
+33,648
| New | +$481K | ﹤0.01% | 3859 |
|